Re-understanding the mechanisms of action of the anti-mycobacterial drug bedaquiline
Bedaquiline (BDQ) inhibits ATP generation in Mycobacterium tuberculosis by interfering with the F-ATP synthase activity. Two mechanisms of action of BDQ are broadly accepted. A direct mechanism involves BDQ binding to the enzyme’s c-ring to block its rotation, thus inhibiting ATP synthesis in the en...
Saved in:
Main Authors: | Sarathy, Jickky Palmae, Gruber, Gerhard, Dick, Thomas |
---|---|
Other Authors: | School of Biological Sciences |
Format: | Article |
Language: | English |
Published: |
2020
|
Subjects: | |
Online Access: | https://hdl.handle.net/10356/138546 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Nanyang Technological University |
Language: | English |
Similar Items
-
Re-understanding the mechanisms of action of the anti-mycobacterial drug bedaquiline
by: Sarathy, J.P., et al.
Published: (2021) -
MECHANISM OF ACTION OF THE ANTI-TUBERCULOSIS DRUG CANDIDATE TBAJ-876
by: JICKKY PALMAE SARATHY
Published: (2020) -
TBAJ-876 displays bedaquiline-like mycobactericidal potency without retaining the parental drug’s uncoupler activity
by: Sarathy, Jickky Palmae, et al.
Published: (2020) -
Binding properties of the anti-TB drugs bedaquiline and TBAJ-876 to a mycobacterial F-ATP synthase
by: Krah, Alexander, et al.
Published: (2022) -
BEDAQUILINE TARGETS THE EPSILON SUBUNIT OF MYCOBACTERIAL F-ATP SYNTHASE
by: SUBHASHRI KUNDU
Published: (2017)